# A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes

> **NCT00853151** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 131 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY2428757
- **DRUG:** TT223
- **DRUG:** Placebo for LY2428757
- **DRUG:** Placebo for TT223

## Key facts

- **NCT ID:** NCT00853151
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2012-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853151, "A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00853151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*